NASDAQ
Apellis Pharmaceuticals, Inc. (APLS) has a free cash flow growth of -336.38% as of Friday, May 29, 2026. This represents a 167.85% decrease compared to its 12-month average of 495.80%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.